Polyrizon Ltd. ( PLRZ ) shares surged 139.77% to $17 in after-hours trading on Wednesday.

Check out the current price of PLRZ stock here.

According to Benzinga Pro data, the stock closed on Wednesday at $7.09, down 3.27%.

Preclinical Data Announcement

The Israel-based biotechnology company on Wednesday announced preclinical test data showing its proprietary naloxone hydrogel adheres to nasal tissue longer than an approved intranasal naloxone spray currently on the market.

Using an ex-vivo rabbit nasal mucosa model, researchers applied each formulation to mucosal tissue and washed it with Simulated Nasal Electrolyte Solution over a 30-minute period.

See Also: These Healthcare Stocks Just Exploded In Momentum — Investors Are Taking Notice

Compared with the commercial product, Polyrizon’s Trap and Target hydrogel showed higher fluorescence marker values, with differences reaching statistical significance (p